NANODIAGNOSTIC TECHNOLOGY, LLC

NanoDiagnostic Technology is an R&D company developing integrated nanosensor-smartphone platforms for rapid, point-of-care biomonitoring of pesticide exposure. Its technology detects organophosphate (OP) pesticide biomarkers from a finger-stick blood sample using a multiplex nanosensing platform paired with a mobile app for data processing and reporting. The company has been awarded STTR Phase I and Phase II funding from the NIH/NIEHS and operates in partnership with the University of North Carolina Charlotte, targeting clinical, agricultural, and occupational health applications.